BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 14987573)

  • 1. Essential biochemistry and physiology of (NT-pro)BNP.
    Hall C
    Eur J Heart Fail; 2004 Mar; 6(3):257-60. PubMed ID: 14987573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NT-ProBNP: the mechanism behind the marker.
    Hall C
    J Card Fail; 2005 Jun; 11(5 Suppl):S81-3. PubMed ID: 15948107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of ANP and BNP to their N-terminal fragments in fetal circulation: evidence for enhanced neutral endopeptidase activity and resistance of BNP to neutral endopeptidase in the fetus.
    Walther T; Stepan H; Pankow K; Gembardt F; Faber R; Schultheiss HP; Siems WE
    BJOG; 2004 May; 111(5):452-5. PubMed ID: 15104609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides in patients with aortic stenosis.
    Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
    Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
    Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
    Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BNP as a biomarker in heart disease.
    Vuolteenaho O; Ala-Kopsala M; Ruskoaho H
    Adv Clin Chem; 2005; 40():1-36. PubMed ID: 16355919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.
    Hystad ME; Geiran OR; Attramadal H; Spurkland A; Vege A ; Simonsen S; Hall C
    Acta Physiol Scand; 2001 Apr; 171(4):395-403. PubMed ID: 11421854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
    Hoffmann U; Brueckmann M; Bertsch T; Wiessner M; Liebetrau C; Lang S; Haase KK; Borggrefe M; Huhle G
    Clin Lab; 2005; 51(7-8):373-9. PubMed ID: 16122147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic peptides and right atrial fibrosis in patients with paroxysmal versus persistent atrial fibrillation.
    Cao H; Xue L; Wu Y; Ma H; Chen L; Wang X; Zhu Q; Dai N; Chen Y
    Peptides; 2010 Aug; 31(8):1531-9. PubMed ID: 20434499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clearance of BNP modeled using the NT-proBNP-BNP relationship.
    Kroll MH; Srisawasdi P
    Biosystems; 2007 Mar; 88(1-2):147-55. PubMed ID: 16860926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Brain natriuretic peptide: physiological, biological and clinical aspects].
    Cauliez B; Berthe MC; Lavoinne A
    Ann Biol Clin (Paris); 2005; 63(1):15-25. PubMed ID: 15689309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the Emergency Department: comparison with brain natriuretic peptide (BNP).
    Chenevier-Gobeaux C; Claessens YE; Voyer S; Desmoulins D; Ekindjian OG
    Clin Chim Acta; 2005 Nov; 361(1-2):167-75. PubMed ID: 15993397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction.
    Gill D; Seidler T; Troughton RW; Yandle TG; Frampton CM; Richards M; Lainchbury JG; Nicholls G
    Clin Sci (Lond); 2004 Feb; 106(2):135-9. PubMed ID: 12974669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
    Forfia PR; Watkins SP; Rame JE; Stewart KJ; Shapiro EP
    J Am Coll Cardiol; 2005 May; 45(10):1667-71. PubMed ID: 15893185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.
    Koch AM; Rauh M; Zink S; Singer H
    Acta Paediatr; 2006 Jul; 95(7):805-9. PubMed ID: 16801175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G; Runkel S; Zdunek D; Hitzler WE
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide infusions in acute myocardial infarction.
    Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
    Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.